Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 4, 2009, Pages 977-984

  Sodha, Neel R ^a   Clements, Richard T ^a   Feng, Jun ^a   Liu, Yuhong ^a   Bianchi, Cesario ^a   Horvath, Eszter M ^b   Szabo, Csaba ^c   Stahl, Gregory L ^d   Sellke, Frank W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b University of Medicine and Dentistry of New Jersey   (United States)

^c MALLINCKRODT PHARMACEUTICALS   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN SULFIDE; INTERLEUKIN 6; INTERLEUKIN 8; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INFLAMMATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CORONARY VESSELS; CYTOKINES; FREE RADICALS; HYDROGEN SULFIDE; IMMUNOHISTOCHEMISTRY; MICROVESSELS; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PEROXIDASE; SWINE;

EID: 70349118533     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.08.074     Document Type: Article

References (33)

1. Moens A.L., Claeys M.J., Timmermans J.P., and Vrints C.J. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 100 (2005) 179-190
2. Manning A.S., and Hearse D.J. Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol 16 (1984) 497-518
3. Ambrosio G., and Tritto I. Clinical manifestations of myocardial stunning. Coron Artery Dis 12 (2001) 357-361
4. Lefer A.M., and Lefer D.J. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 32 (1996) 743-751
5. Roberts M.J., Young I.S., Trouton T.G., Trimble E.R., Khan M.M., Webb S.W., et al. Transient release of lipid peroxides after coronary artery balloon angioplasty. Lancet 336 (1990) 143-145
6. Kloner R.A., Giacomelli F., Alker K.J., Hale S.L., Matthews R., and Bellows S. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation 84 (1991) 1758-1772
7. Whiteman M., Armstrong J.S., Chu S.H., Jia-Ling S., Wong B.S., Cheung N.S., et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'?. J Neurochem 90 (2004) 765-768
8. Fiorucci S., Antonelli E., Distrutti E., Rizzo G., Mencarelli A., Orlandi S., et al. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 129 (2005) 1210-1224
9. Hu L.F., Wong P.T., Moore P.K., and Bian J.S. Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem 100 (2007) 1121-1128
10. Mitsuhashi H., Yamashita S., Ikeuchi H., Kuroiwa T., Kaneko Y., Hiromura K., et al. Oxidative stress-dependent conversion of hydrogen sulfide to sulfite by activated neutrophils. Shock 24 (2005) 529-534
11. Geng B., Chang L., Pan C., Qi Y., Zhao J., Pang Y., et al. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 318 (2004) 756-763
12. Zhu Y.Z., Wang Z.J., Ho P., Loke Y.Y., Zhu Y.C., Huang S.H., et al. Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. J Appl Physiol 102 (2007) 261-268
13. Sivarajah A., McDonald M.C., and Thiemermann C. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock 26 (2006) 154-161
14. Tofukuji M., Metais C., Li J., Hariawala M.D., Franklin A., Vassileva C., et al. Effects of ischemic preconditioning on myocardial perfusion, function, and microvascular regulation. Circulation 98 (1998) II197-II204 discussion II204-5
15. Amsterdam E.A., Stahl G.L., Pan H.L., Rendig S.V., Fletcher M.P., and Longhurst J.C. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. Am J Physiol 268 (1995) H448-H457
16. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445 (2007) 771-775
17. Sodha N.R., Clements R.T., Feng J., Liu Y., Bianchi C., Horvath E.M., et al. The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg 33 (2008) 906-913
18. Johansen D., Ytrehus K., and Baxter G.F. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury-Evidence for a role of K ATP channels. Basic Res Cardiol 101 (2006) 53-60
19. Elrod J.W., Calvert J.W., Morrison J., Doeller J.E., Kraus D.W., Tao L., et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A 104 (2007) 15560-15565
20. Zanardo R.C., Brancaleone V., Distrutti E., Fiorucci S., Cirino G., and Wallace J.L. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. Faseb J 20 (2006) 2118-2120
21. Lawton J.S., Sepic J.D., Allen C.T., Hsia P.W., and Damiano Jr. R.J. Myocardial protection with potassium-channel openers is as effective as St. Thomas' solution in the rabbit heart. Ann Thorac Surg 62 (1996) 31-38 discussion 38-9
22. Miura T., and Miki T. ATP-sensitive K+ channel openers: old drugs with new clinical benefits for the heart. Curr Vasc Pharmacol 1 (2003) 251-258
23. Kukielka G.L., Smith C.W., Manning A.M., Youker K.A., Michael L.H., and Entman M.L. Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation 92 (1995) 1866-1875
24. Hennein H.A., Ebba H., Rodriguez J.L., Merrick S.H., Keith F.M., Bronstein M.H., et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 108 (1994) 626-635
25. Kukielka G.L., Smith C.W., LaRosa G.J., Manning A.M., Mendoza L.H., Daly T.J., et al. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 95 (1995) 89-103
26. Dinarello C.A. Proinflammatory cytokines. Chest 118 (2000) 503-508
27. Nian M., Lee P., Khaper N., and Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94 (2004) 1543-1553
28. Herrera-Garza E.H., Stetson S.J., Cubillos-Garzon A., Vooletich M.T., Farmer J.A., and Torre-Amione G. Tumor necrosis factor-alpha: a mediator of disease progression in the failing human heart. Chest 115 (1999) 1170-1174
29. Hein T.W., Zhang C., Wang W., Chang C.I., Thengchaisri N., and Kuo L. Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. Faseb J 17 (2003) 2328-2330
30. Ito H., Tomooka T., Sakai N., Yu H., Higashino Y., Fujii K., et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 85 (1992) 1699-1705
31. Prasad A., and Gersh B.J. Management of microvascular dysfunction and reperfusion injury. Heart 91 (2005) 1530-1532
32. Zhang C., Xu X., Potter B.J., Wang W., Kuo L., Michael L., et al. TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 26 (2006) 475-480
33. Prasad A., Stone G.W., Aymong E., Zimetbaum P.J., McLaughlin M., Mehran R., et al. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. Am Heart J 147 (2004) 669-675